DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Abstract

Here, we analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer.

Authors:
 [1];  [2];  [3];  [2];  [2];  [2];  [2];  [4];  [2];  [2];  [5];  [2];  [6];  [7];  [8];  [9];  [10];  [9];  [3];  [11] more »;  [12];  [13];  [14];  [2];  [15];  [16];  [2];  [17];  [6];  [2];  [18];  [19];  [2];  [20];  [21];  [22];  [19];  [20];  [2];  [2];  [2];  [2];  [2];  [23];  [24];  [25];  [2];  [2];  [6];  [26];  [6];  [27];  [2];  [2];  [28];  [2];  [29];  [12];  [30];  [30];  [31];  [2];  [32];  [14];  [33];  [34];  [35];  [14];  [3];  [22];  [15];  [36];  [37];  [2];  [38];  [16];  [39];  [28];  [40];  [8];  [7];  [18];  [6];  [9];  [41];  [20];  [42];  [2] « less
  1. Wellcome Trust Sanger Institute, Cambridge (United Kingdom); Cambridge Univ. Hospitals NHS Foundation Trust, Cambridge (United Kingdom)
  2. Wellcome Trust Sanger Institute, Cambridge (United Kingdom)
  3. Lund Univ., Lund (Sweden)
  4. Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Wellcome Trust Sanger Institute, Cambridge (United Kingdom)
  5. Wellcome Trust Sanger Institute, Cambridge (United Kingdom); Univ. of Leuven, Leuven (Belgium)
  6. Erasmus Univ. Medical Center, Rotterdam (The Netherlands)
  7. Radboud Univ., Nijmegen (The Netherlands)
  8. Wellcome Trust Genome Campus, Cambridge (United Kingdom)
  9. Oslo Univ. Hospital, Oslo (Norway); Univ. of Oslo, Oslo (Norway)
  10. Univ. of Oslo, Oslo (Norway)
  11. Gachon Univ. Gil Medical Center, Incheon (South Korea)
  12. Centre Leon Berard, Lyon Cedex (France)
  13. Brigham and Women's Hospital, Boston, MA (United States)
  14. The Netherlands Cancer Institute, Amsterdam (The Netherlands)
  15. Univ. Libre de Bruxelles, Brussels (Belgium)
  16. Univ. of Antwerp, Antwerp (Belgium)
  17. Dana-Farber Cancer Institute, Boston, MA (United States)
  18. Academic Medical Center, Amsterdam (The Netherlands)
  19. Ulsan Univ., Ulsan (South Korea)
  20. Hanyang Univ., Seoul (South Korea)
  21. Memorial Sloan Kettering Cancer Center, New York, NY (United States)
  22. The Univ. of Texas MD Anderson Cancer Center, Houston, TX (United States)
  23. Institut National du Cancer, Boulogne-Billancourt (France)
  24. Univ. Hospital of Minjoz, Besancon (France)
  25. Ninewells Hospital and Medical School, Dundee (United Kingdom)
  26. ICM Institut Regional du Cancer, Montpellier (France)
  27. The Univ. of Queensland, Queensland (Australia)
  28. Univ. of Iceland, Reykjavik (Iceland)
  29. IRCCS Istiuto Tumori "Giovanni Paolo II", Bari (Italy)
  30. Univ. of Antwerp, Antwerp (Belgium); GZA Hospitals Sint-Augustinus, Antwerp (Belgium)
  31. Paris Sciences Lettres Univ., Paris Cedex (France)
  32. Univ. of Cambridge, Cambridge (United Kingdom)
  33. King's College London, London (United Kingdom); Breast Cancer Now Toby Robins Research Center, London (United Kingdom)
  34. Univ. of Bergen, Bergen (Norway); Haukeland Univ. Hospital, Bergen (Norway)
  35. Singapore General Hospital (Singapore)
  36. INRIA Grenoble-Rhone-Alpes, Montbonnot-Saint Martin (France); Synergie Lyon Cancer, Lyon Cedex (France)
  37. Wellcome Trust Sanger Institute, Cambridge (United Kingdom); UT MD Anderson Cancer Center, Houston, TX (United States)
  38. Radboud Univ. Medical Center, Nijmegen (The Netherlands)
  39. The Univ. of Queensland, Queensland (Australia); The Royal Brisbane and Women's Hospital, Queensland (Australia)
  40. Ninewells Hospital and Medical School, Dundee (United Kingdom); Univ. of Texas MD Anderson Cancer Center, Houston, TX (United States)
  41. Brigham and Women's Hospital, Boston, MA (United States); Dana-Farber Cancer Institute, Boston, MA (United States)
  42. Synergie Lyon Cancer, Lyon Cedex (France)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1255873
Report Number(s):
LA-UR-15-24625
Journal ID: ISSN 0028-0836
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Nature (London)
Additional Journal Information:
Journal Name: Nature (London); Journal Volume: 534; Journal Issue: 7605; Journal ID: ISSN 0028-0836
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Biological Science

Citation Formats

Nik-Zainal, Serena, Davies, Helen, Staaf, Johan, Ramakrishna, Manasa, Glodzik, Dominik, Zou, Xueqing, Martincorena, Inigo, Alexandrov, Ludmil B., Martin, Sancha, Wedge, David C., Van Loo, Peter, Ju, Young Seok, Smid, Marcel, Brinkman, Arie B., Morganella, Sandro, Aure, Miriam R., Lingjærde, Ole Christian, Langerod, Anita, Ringner, Markus, Ahn, Sung -Min, Boyault, Sandrine, Brock, Jane E., Broeks, Annegien, Butler, Adam, Desmedt, Christine, Dirix, Luc, Dronov, Serge, Fatima, Aquila, Foekens, John A., Gerstung, Moritz, Hooijer, Gerrit K. J., Jang, Se Jin, Jones, David R., Kim, Hyung -Yong, King, Tari A., Krishnamurthy, Savitri, Lee, Hee Jin, Lee, Jeong -Yeon, Li, Yilong, McLaren, Stuart, Menzies, Andrew, Mustonen, Ville, O’Meara, Sarah, Pauporte, Iris, Pivot, Xavier, Purdie, Colin A., Raine, Keiran, Ramakrishnan, Kamna, Rodríguez-Gonzalez, F. German, Romieu, Gilles, Sieuwerts, Anieta M., Simpson, Peter T., Shepherd, Rebecca, Stebbings, Lucy, Stefansson, Olafur A., Teague, Jon, Tommasi, Stefania, Treilleux, Isabelle, Van den Eynden, Gert G., Vermeulen, Peter, Vincent-Salomon, Anne, Yates, Lucy, Caldas, Carlos, Veer, Laura van’t, Tutt, Andrew, Knappskog, Stian, Tan, Benita Kiat Tee, Jonkers, Jos, Borg, Ake, Ueno, Naoto T., Sotiriou, Christos, Viari, Alain, Futreal, P. Andrew, Campbell, Peter J., Span, Paul N., Van Laere, Steven, Lakhani, Sunil R., Eyfjord, Jorunn E., Thompson, Alastair M., Birney, Ewan, Stunnenberg, Hendrik G., van de Vijver, Marc J., Martens, John W. M., Borresen-Dale, Anne -Lise, Richardson, Andrea L., Kong, Gu, Thomas, Gilles, and Stratton, Michael R. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. United States: N. p., 2016. Web. doi:10.1038/nature17676.
Nik-Zainal, Serena, Davies, Helen, Staaf, Johan, Ramakrishna, Manasa, Glodzik, Dominik, Zou, Xueqing, Martincorena, Inigo, Alexandrov, Ludmil B., Martin, Sancha, Wedge, David C., Van Loo, Peter, Ju, Young Seok, Smid, Marcel, Brinkman, Arie B., Morganella, Sandro, Aure, Miriam R., Lingjærde, Ole Christian, Langerod, Anita, Ringner, Markus, Ahn, Sung -Min, Boyault, Sandrine, Brock, Jane E., Broeks, Annegien, Butler, Adam, Desmedt, Christine, Dirix, Luc, Dronov, Serge, Fatima, Aquila, Foekens, John A., Gerstung, Moritz, Hooijer, Gerrit K. J., Jang, Se Jin, Jones, David R., Kim, Hyung -Yong, King, Tari A., Krishnamurthy, Savitri, Lee, Hee Jin, Lee, Jeong -Yeon, Li, Yilong, McLaren, Stuart, Menzies, Andrew, Mustonen, Ville, O’Meara, Sarah, Pauporte, Iris, Pivot, Xavier, Purdie, Colin A., Raine, Keiran, Ramakrishnan, Kamna, Rodríguez-Gonzalez, F. German, Romieu, Gilles, Sieuwerts, Anieta M., Simpson, Peter T., Shepherd, Rebecca, Stebbings, Lucy, Stefansson, Olafur A., Teague, Jon, Tommasi, Stefania, Treilleux, Isabelle, Van den Eynden, Gert G., Vermeulen, Peter, Vincent-Salomon, Anne, Yates, Lucy, Caldas, Carlos, Veer, Laura van’t, Tutt, Andrew, Knappskog, Stian, Tan, Benita Kiat Tee, Jonkers, Jos, Borg, Ake, Ueno, Naoto T., Sotiriou, Christos, Viari, Alain, Futreal, P. Andrew, Campbell, Peter J., Span, Paul N., Van Laere, Steven, Lakhani, Sunil R., Eyfjord, Jorunn E., Thompson, Alastair M., Birney, Ewan, Stunnenberg, Hendrik G., van de Vijver, Marc J., Martens, John W. M., Borresen-Dale, Anne -Lise, Richardson, Andrea L., Kong, Gu, Thomas, Gilles, & Stratton, Michael R. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. United States. https://doi.org/10.1038/nature17676
Nik-Zainal, Serena, Davies, Helen, Staaf, Johan, Ramakrishna, Manasa, Glodzik, Dominik, Zou, Xueqing, Martincorena, Inigo, Alexandrov, Ludmil B., Martin, Sancha, Wedge, David C., Van Loo, Peter, Ju, Young Seok, Smid, Marcel, Brinkman, Arie B., Morganella, Sandro, Aure, Miriam R., Lingjærde, Ole Christian, Langerod, Anita, Ringner, Markus, Ahn, Sung -Min, Boyault, Sandrine, Brock, Jane E., Broeks, Annegien, Butler, Adam, Desmedt, Christine, Dirix, Luc, Dronov, Serge, Fatima, Aquila, Foekens, John A., Gerstung, Moritz, Hooijer, Gerrit K. J., Jang, Se Jin, Jones, David R., Kim, Hyung -Yong, King, Tari A., Krishnamurthy, Savitri, Lee, Hee Jin, Lee, Jeong -Yeon, Li, Yilong, McLaren, Stuart, Menzies, Andrew, Mustonen, Ville, O’Meara, Sarah, Pauporte, Iris, Pivot, Xavier, Purdie, Colin A., Raine, Keiran, Ramakrishnan, Kamna, Rodríguez-Gonzalez, F. German, Romieu, Gilles, Sieuwerts, Anieta M., Simpson, Peter T., Shepherd, Rebecca, Stebbings, Lucy, Stefansson, Olafur A., Teague, Jon, Tommasi, Stefania, Treilleux, Isabelle, Van den Eynden, Gert G., Vermeulen, Peter, Vincent-Salomon, Anne, Yates, Lucy, Caldas, Carlos, Veer, Laura van’t, Tutt, Andrew, Knappskog, Stian, Tan, Benita Kiat Tee, Jonkers, Jos, Borg, Ake, Ueno, Naoto T., Sotiriou, Christos, Viari, Alain, Futreal, P. Andrew, Campbell, Peter J., Span, Paul N., Van Laere, Steven, Lakhani, Sunil R., Eyfjord, Jorunn E., Thompson, Alastair M., Birney, Ewan, Stunnenberg, Hendrik G., van de Vijver, Marc J., Martens, John W. M., Borresen-Dale, Anne -Lise, Richardson, Andrea L., Kong, Gu, Thomas, Gilles, and Stratton, Michael R. Mon . "Landscape of somatic mutations in 560 breast cancer whole-genome sequences". United States. https://doi.org/10.1038/nature17676. https://www.osti.gov/servlets/purl/1255873.
@article{osti_1255873,
title = {Landscape of somatic mutations in 560 breast cancer whole-genome sequences},
author = {Nik-Zainal, Serena and Davies, Helen and Staaf, Johan and Ramakrishna, Manasa and Glodzik, Dominik and Zou, Xueqing and Martincorena, Inigo and Alexandrov, Ludmil B. and Martin, Sancha and Wedge, David C. and Van Loo, Peter and Ju, Young Seok and Smid, Marcel and Brinkman, Arie B. and Morganella, Sandro and Aure, Miriam R. and Lingjærde, Ole Christian and Langerod, Anita and Ringner, Markus and Ahn, Sung -Min and Boyault, Sandrine and Brock, Jane E. and Broeks, Annegien and Butler, Adam and Desmedt, Christine and Dirix, Luc and Dronov, Serge and Fatima, Aquila and Foekens, John A. and Gerstung, Moritz and Hooijer, Gerrit K. J. and Jang, Se Jin and Jones, David R. and Kim, Hyung -Yong and King, Tari A. and Krishnamurthy, Savitri and Lee, Hee Jin and Lee, Jeong -Yeon and Li, Yilong and McLaren, Stuart and Menzies, Andrew and Mustonen, Ville and O’Meara, Sarah and Pauporte, Iris and Pivot, Xavier and Purdie, Colin A. and Raine, Keiran and Ramakrishnan, Kamna and Rodríguez-Gonzalez, F. German and Romieu, Gilles and Sieuwerts, Anieta M. and Simpson, Peter T. and Shepherd, Rebecca and Stebbings, Lucy and Stefansson, Olafur A. and Teague, Jon and Tommasi, Stefania and Treilleux, Isabelle and Van den Eynden, Gert G. and Vermeulen, Peter and Vincent-Salomon, Anne and Yates, Lucy and Caldas, Carlos and Veer, Laura van’t and Tutt, Andrew and Knappskog, Stian and Tan, Benita Kiat Tee and Jonkers, Jos and Borg, Ake and Ueno, Naoto T. and Sotiriou, Christos and Viari, Alain and Futreal, P. Andrew and Campbell, Peter J. and Span, Paul N. and Van Laere, Steven and Lakhani, Sunil R. and Eyfjord, Jorunn E. and Thompson, Alastair M. and Birney, Ewan and Stunnenberg, Hendrik G. and van de Vijver, Marc J. and Martens, John W. M. and Borresen-Dale, Anne -Lise and Richardson, Andrea L. and Kong, Gu and Thomas, Gilles and Stratton, Michael R.},
abstractNote = {Here, we analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer.},
doi = {10.1038/nature17676},
journal = {Nature (London)},
number = 7605,
volume = 534,
place = {United States},
year = {Mon May 02 00:00:00 EDT 2016},
month = {Mon May 02 00:00:00 EDT 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 1314 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

The cancer genome
journal, April 2009

  • Stratton, Michael R.; Campbell, Peter J.; Futreal, P. Andrew
  • Nature, Vol. 458, Issue 7239
  • DOI: 10.1038/nature07943

Mutational Processes Molding the Genomes of 21 Breast Cancers
journal, May 2012


The Life History of 21 Breast Cancers
journal, May 2012


Novel patterns of genome rearrangement and their association with survival in breast cancer
journal, October 2006

  • Hicks, J.; Krasnitz, A.; Lakshmi, B.
  • Genome Research, Vol. 16, Issue 12
  • DOI: 10.1101/gr.5460106

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
journal, November 2007

  • Bergamaschi, A.; Tagliabue, E.; Sørlie, T.
  • The Journal of Pathology, Vol. 214, Issue 3
  • DOI: 10.1002/path.2278

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
journal, April 2012

  • Curtis, Christina; Shah, Sohrab P.; Chin, Suet-Feung
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature10983

A comprehensive catalogue of somatic mutations from a human cancer genome
journal, December 2009

  • Pleasance, Erin D.; Cheetham, R. Keira; Stephens, Philip J.
  • Nature, Vol. 463, Issue 7278
  • DOI: 10.1038/nature08658

A small-cell lung cancer genome with complex signatures of tobacco exposure
journal, December 2009

  • Pleasance, Erin D.; Stephens, Philip J.; O’Meara, Sarah
  • Nature, Vol. 463, Issue 7278
  • DOI: 10.1038/nature08629

Sequence analysis of mutations and translocations across breast cancer subtypes
journal, June 2012

  • Banerji, Shantanu; Cibulskis, Kristian; Rangel-Escareno, Claudia
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature11154

Whole-genome analysis informs breast cancer response to aromatase inhibition
journal, June 2012

  • Ellis, Matthew J.; Ding, Li; Shen, Dong
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature11143

The clonal and mutational evolution spectrum of primary triple-negative breast cancers
journal, April 2012

  • Shah, Sohrab P.; Roth, Andrew; Goya, Rodrigo
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature10933

The landscape of cancer genes and mutational processes in breast cancer
journal, May 2012

  • Stephens, Philip J.; Tarpey, Patrick S.; Davies, Helen
  • Nature, Vol. 486, Issue 7403
  • DOI: 10.1038/nature11017

Identification of Targetable FGFR Gene Fusions in Diverse Cancers
journal, April 2013


Breakpoint Analysis of Transcriptional and Genomic Profiles Uncovers Novel Gene Fusions Spanning Multiple Human Cancer Types
journal, April 2013


Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
journal, November 2011

  • Robinson, Dan R.; Kalyana-Sundaram, Shanker; Wu, Yi-Mi
  • Nature Medicine, Vol. 17, Issue 12
  • DOI: 10.1038/nm.2580

Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney
journal, February 2015


Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics
journal, October 2013


The Long Noncoding RNAs NEAT1 and MALAT1 Bind Active Chromatin Sites
journal, September 2014


Highly Recurrent TERT Promoter Mutations in Human Melanoma
journal, January 2013


Frequency of TERT promoter mutations in human cancers
journal, July 2013

  • Vinagre, João; Almeida, Ana; Pópulo, Helena
  • Nature Communications, Vol. 4, Issue 1
  • DOI: 10.1038/ncomms3185

Signatures of mutational processes in human cancer
journal, August 2013

  • Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
  • Nature, Vol. 500, Issue 7463
  • DOI: 10.1038/nature12477

Deciphering Signatures of Mutational Processes Operative in Human Cancer
journal, January 2013


Discovery and saturation analysis of cancer genes across 21 tumour types
journal, January 2014

  • Lawrence, Michael S.; Stojanov, Petar; Mermel, Craig H.
  • Nature, Vol. 505, Issue 7484
  • DOI: 10.1038/nature12912

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast: Molecular heterogeneity of breast micropapillary carcinomas
journal, February 2014

  • Natrajan, Rachael; Wilkerson, Paul M.; Marchiò, Caterina
  • The Journal of Pathology, Vol. 232, Issue 5
  • DOI: 10.1002/path.4325

Gene Fusions Associated with Recurrent Amplicons Represent a Class of Passenger Aberrations in Breast Cancer
journal, August 2012

  • Kalyana-Sundaram, Shanker; Shankar, Sunita; DeRoo, Scott
  • Neoplasia, Vol. 14, Issue 8
  • DOI: 10.1593/neo.12914

Somatic structural variation and cancer
journal, April 2015

  • Tubio, Jose M. C.
  • Briefings in Functional Genomics, Vol. 14, Issue 5
  • DOI: 10.1093/bfgp/elv016

Genome-wide analysis of noncoding regulatory mutations in cancer
journal, September 2014

  • Weinhold, Nils; Jacobsen, Anders; Schultz, Nikolaus
  • Nature Genetics, Vol. 46, Issue 11
  • DOI: 10.1038/ng.3101

Genome Update: DNA repeats in bacterial genomes
journal, November 2004


Short Inverted Repeats Are Hotspots for Genetic Instability: Relevance to Cancer Genomes
journal, March 2015


Replication stalling at unstable inverted repeats: Interplay between DNA hairpins and fork stabilizing proteins
journal, July 2008

  • Voineagu, I.; Narayanan, V.; Lobachev, K. S.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 29
  • DOI: 10.1073/pnas.0804510105

Inverted repeats, stem-loops, and cruciforms: Significance for initiation of DNA replication
journal, October 1996


Interpreting cDNA sequences: Some insights from studies on translation
journal, August 1996


Mechanisms underlying mutational signatures in human cancers
journal, July 2014

  • Helleday, Thomas; Eshtad, Saeed; Nik-Zainal, Serena
  • Nature Reviews Genetics, Vol. 15, Issue 9
  • DOI: 10.1038/nrg3729

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
journal, October 2012

  • Abkevich, V.; Timms, K. M.; Hennessy, B. T.
  • British Journal of Cancer, Vol. 107, Issue 10
  • DOI: 10.1038/bjc.2012.451

Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation
journal, August 2012


Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
journal, June 2011

  • Puente, Xose S.; Pinyol, Magda; Quesada, Víctor
  • Nature, Vol. 475, Issue 7354
  • DOI: 10.1038/nature10113

The topography of mutational processes in breast cancer genomes
journal, May 2016

  • Morganella, Sandro; Alexandrov, Ludmil B.; Glodzik, Dominik
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms11383

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
journal, July 2009

  • Fong, Peter C.; Boss, David S.; Yap, Timothy A.
  • New England Journal of Medicine, Vol. 361, Issue 2
  • DOI: 10.1056/NEJMoa0900212

Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
journal, April 2011

  • Forster, Martin D.; Dedes, Konstantin J.; Sandhu, Shahneen
  • Nature Reviews Clinical Oncology, Vol. 8, Issue 5
  • DOI: 10.1038/nrclinonc.2011.42

Targeting the DNA repair defect of BRCA tumours
journal, August 2005


Whole genomes redefine the mutational landscape of pancreatic cancer
journal, February 2015

  • Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie
  • Nature, Vol. 518, Issue 7540
  • DOI: 10.1038/nature14169

Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes
journal, March 2009

  • Kozarewa, Iwanka; Ning, Zemin; Quail, Michael A.
  • Nature Methods, Vol. 6, Issue 4
  • DOI: 10.1038/nmeth.1311

Fast and accurate short read alignment with Burrows-Wheeler transform
journal, May 2009


Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
journal, February 2008


Allele-specific copy number analysis of tumors
journal, September 2010

  • Van Loo, P.; Nordgard, S. H.; Lingjaerde, O. C.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 39
  • DOI: 10.1073/pnas.1009843107

Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer
journal, June 2006


Mutational heterogeneity in cancer and the search for new cancer-associated genes
journal, June 2013

  • Lawrence, Michael S.; Stojanov, Petar; Polak, Paz
  • Nature, Vol. 499, Issue 7457
  • DOI: 10.1038/nature12213

Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies
journal, January 2006

  • Sun, Lei; Craiu, Radu V.; Paterson, Andrew D.
  • Genetic Epidemiology, Vol. 30, Issue 6
  • DOI: 10.1002/gepi.20164

An integrated encyclopedia of DNA elements in the human genome
journal, September 2012


ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
journal, April 2010


ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors
journal, March 2008


Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
journal, January 2014


An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
journal, April 2008

  • Ben-Porath, Ittai; Thomson, Matthew W.; Carey, Vincent J.
  • Nature Genetics, Vol. 40, Issue 5
  • DOI: 10.1038/ng.127

Inactivation of Capicua drives cancer metastasis
journal, November 2016

  • Okimoto, Ross A.; Breitenbuecher, Frank; Olivas, Victor R.
  • Nature Genetics, Vol. 49, Issue 1
  • DOI: 10.1038/ng.3728

Integrins in cancer: biological implications and therapeutic opportunities
journal, January 2010

  • Desgrosellier, Jay S.; Cheresh, David A.
  • Nature Reviews Cancer, Vol. 10, Issue 1
  • DOI: 10.1038/nrc2748

Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer
journal, August 2018


Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation
journal, May 2006

  • Kawamura-Saito, Miho; Yamazaki, Yukari; Kaneko, Keiko
  • Human Molecular Genetics, Vol. 15, Issue 13
  • DOI: 10.1093/hmg/ddl136

Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma
journal, July 2017

  • Simón-Carrasco, Lucía; Graña, Osvaldo; Salmón, Marina
  • Genes & Development, Vol. 31, Issue 14
  • DOI: 10.1101/gad.300244.117

The Biology of Cancer Stem Cells
journal, November 2007


Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells
journal, September 2006


Capicua suppresses colorectal cancer progression via repression of ETV4 expression
journal, February 2020


The Capicua repressor - a general sensor of RTK signaling in development and disease
journal, March 2012

  • Jimenez, G.; Shvartsman, S. Y.; Paroush, Z.
  • Journal of Cell Science, Vol. 125, Issue 6
  • DOI: 10.1242/jcs.092965

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
text, January 2012

  • Curtis, Christina; Shah, Sohrab P.; Chin, Suet-Feung
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.49208

Signatures of mutational processes in human cancer.
text, January 2013

  • Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.31889

Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
text, January 2011

  • Forster, M. D.; Dedes, K. J.; Sandhu, S.
  • Nature Publishing Group
  • DOI: 10.5167/uzh-59244

Allele-specific copy number analysis of tumors
text, January 2010

  • B., Naume,; W., Sun,; C., Lingjaerde, O.
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/2zsb-7679

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
text, January 2010

  • Neil, Hayes, D.; D., Wilkerson, Matthew
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/x6qg-hc56

Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies
journal, January 2006

  • Sun, Lei; Craiu, Radu V.; Paterson, Andrew D.
  • Genetic Epidemiology, Vol. 30, Issue 6
  • DOI: 10.1002/gepi.20164

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast: Molecular heterogeneity of breast micropapillary carcinomas
journal, February 2014

  • Natrajan, Rachael; Wilkerson, Paul M.; Marchiò, Caterina
  • The Journal of Pathology, Vol. 232, Issue 5
  • DOI: 10.1002/path.4325

Emergence of truly “Individualized” therapy: The poly (adenosine diphosphate-ribose) polymerase inhibitors
journal, October 2009


Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney
journal, February 2015


Targeting the DNA repair defect of BRCA tumours
journal, August 2005


An integrated encyclopedia of DNA elements in the human genome
journal, September 2012


Whole genomes redefine the mutational landscape of pancreatic cancer
journal, February 2015

  • Waddell, Nicola; Pajic, Marina; Patch, Ann-Marie
  • Nature, Vol. 518, Issue 7540
  • DOI: 10.1038/nature14169

Differences that matter in cancer genomics
journal, October 2013

  • Ding, Li; Wendl, Michael C.
  • Nature Biotechnology, Vol. 31, Issue 10
  • DOI: 10.1038/nbt.2715

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
journal, April 2010


Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
journal, February 2008


Highly Recurrent TERT Promoter Mutations in Human Melanoma
journal, January 2013


Telomeric Allelic Imbalance Indicates Defective DNA Repair and Sensitivity to DNA-Damaging Agents
journal, March 2012


RCircos: an R package for Circos 2D track plots
journal, January 2013


Works referencing / citing this record:

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers
journal, January 2020

  • Bertucci, François; Rypens, Charlotte; Finetti, Pascal
  • Molecular Oncology, Vol. 14, Issue 3
  • DOI: 10.1002/1878-0261.12621

Molecular Biology of Breast Cancer
book, November 2016


Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
journal, April 2019

  • Taylor, Justin; Lee, Stanley C.
  • Genes, Chromosomes and Cancer, Vol. 58, Issue 12
  • DOI: 10.1002/gcc.22784

Variant classification in precision oncology
journal, May 2019

  • Leichsenring, Jonas; Horak, Peter; Kreutzfeldt, Simon
  • International Journal of Cancer, Vol. 145, Issue 11
  • DOI: 10.1002/ijc.32358

Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
journal, June 2019

  • Wang, Shengfeng; Pitt, Jason J.; Zheng, Yonglan
  • International Journal of Cancer, Vol. 145, Issue 12
  • DOI: 10.1002/ijc.32498

Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapy
journal, November 2018

  • Kyrochristos, Ioannis D.; Ziogas, Demosthenes E.; Roukos, Dimitrios H.
  • Medicinal Research Reviews, Vol. 39, Issue 3
  • DOI: 10.1002/med.21549

NTHL1 and MUTYH polyposis syndromes: two sides of the same coin?: Base excision repair polyposis syndromes
journal, December 2017

  • Weren, Robbert DA; Ligtenberg, Marjolijn JL; Geurts van Kessel, Ad
  • The Journal of Pathology, Vol. 244, Issue 2
  • DOI: 10.1002/path.5002

Phenotypic and molecular dissection of metaplastic breast cancer and the prognostic implications: Prognostic features of metaplastic breast cancer
journal, December 2018

  • McCart Reed, Amy Ellen; Kalaw, Emarene; Nones, Katia
  • The Journal of Pathology, Vol. 247, Issue 2
  • DOI: 10.1002/path.5184

Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile
journal, August 2019

  • Hofvander, Jakob; Puls, Florian; Pillay, Nischalan
  • The Journal of Pathology, Vol. 249, Issue 4
  • DOI: 10.1002/path.5326

A genome-wide analysis of colorectal cancer in a child with Noonan syndrome
journal, July 2018

  • Prasad, Rahul M.; Mody, Rajen J.; Myers, George
  • Pediatric Blood & Cancer, Vol. 65, Issue 11
  • DOI: 10.1002/pbc.27362

A Summary of the Biological Processes, Disease-Associated Changes, and Clinical Applications of DNA Methylation
book, December 2017


Identification of frequent somatic mutations in inflammatory breast cancer
journal, February 2017

  • Matsuda, Naoko; Lim, Bora; Wang, Ying
  • Breast Cancer Research and Treatment, Vol. 163, Issue 2
  • DOI: 10.1007/s10549-017-4165-0

How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective
journal, June 2019

  • Swiatnicki, Matthew R.; Andrechek, Eran R.
  • Journal of Mammary Gland Biology and Neoplasia, Vol. 24, Issue 3
  • DOI: 10.1007/s10911-019-09433-3

Two-phase SSU and SKAT in genetic association studies
journal, January 2020


Analysis of somatic microsatellite indels identifies driver events in human tumors
journal, September 2017

  • Maruvka, Yosef E.; Mouw, Kent W.; Karlic, Rosa
  • Nature Biotechnology, Vol. 35, Issue 10
  • DOI: 10.1038/nbt.3966

Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
journal, August 2016

  • Zhang, Weiguo; Mao, Jian-Hua; Zhu, Wei
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12619

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
journal, August 2017

  • Polak, Paz; Kim, Jaegil; Braunstein, Lior Z.
  • Nature Genetics, Vol. 49, Issue 10
  • DOI: 10.1038/ng.3934

Bayesian inference of negative and positive selection in human cancers
journal, November 2017

  • Weghorn, Donate; Sunyaev, Shamil
  • Nature Genetics, Vol. 49, Issue 12
  • DOI: 10.1038/ng.3987

Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
journal, March 2017

  • Foo, T. K.; Tischkowitz, M.; Simhadri, S.
  • Oncogene, Vol. 36, Issue 29
  • DOI: 10.1038/onc.2017.46

Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression
journal, January 2019


CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3
journal, February 2019


Mutational processes contributing to the development of multiple myeloma
journal, August 2019


Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers
journal, April 2018


The effects of mutational processes and selection on driver mutations across cancer types
journal, May 2018


Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants
journal, June 2018


Whole-genome sequencing reveals novel tandem-duplication hotspots and a prognostic mutational signature in gastric cancer
journal, May 2019


Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes
journal, July 2019

  • Koedoot, Esmee; Fokkelman, Michiel; Rogkoti, Vasiliki-Maria
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-11020-3

A practical guide for mutational signature analysis in hematological malignancies
journal, July 2019


Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
journal, July 2019


Detailed modeling of positive selection improves detection of cancer driver genes
journal, July 2019


Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
journal, October 2019


Structural basis for adhesion G protein-coupled receptor Gpr126 function
journal, January 2020

  • Leon, Katherine; Cunningham, Rebecca L.; Riback, Joshua A.
  • Nature Communications, Vol. 11, Issue 1
  • DOI: 10.1038/s41467-019-14040-1

Intra-tumour diversification in colorectal cancer at the single-cell level
journal, April 2018


Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
journal, April 2018


The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
journal, September 2019


Identification of cancer driver genes based on nucleotide context
journal, February 2020


Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress
journal, September 2018


Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans
journal, January 2020


Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes
journal, April 2020


Leveraging premalignant biology for immune-based cancer prevention
journal, September 2016

  • Spira, Avrum; Disis, Mary L.; Schiller, John T.
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 39
  • DOI: 10.1073/pnas.1608077113

The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment
journal, January 2020


Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies
journal, January 2018


Modeling clinical and molecular covariates of mutational process activity in cancer
journal, July 2019


The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
journal, February 2018

  • Weigelt, Britta; Bi, Rui; Kumar, Rahul
  • JNCI: Journal of the National Cancer Institute, Vol. 110, Issue 9
  • DOI: 10.1093/jnci/djy028

Modeling Breast Cancer Using CRISPR-Cas9–Mediated Engineering of Human Breast Organoids
journal, October 2019

  • Dekkers, Johanna F.; Whittle, James R.; Vaillant, François
  • JNCI: Journal of the National Cancer Institute, Vol. 112, Issue 5
  • DOI: 10.1093/jnci/djz196

Germline determinants of the somatic mutation landscape in 2,642 cancer genomes
posted_content, November 2017


Insights into the mutational burden of human induced pluripotent stem cells using an integrative omics approach
posted_content, June 2018

  • D’Antonio, Matteo; Benaglio, Paola; Jakubosky, David
  • bioRxiv
  • DOI: 10.1101/334870

Modeling the MYC-driven normal-to-tumour switch in breast cancer
posted_content, August 2018

  • Lourenco, Corey; Kalkat, Manpreet; Houlahan, Kathleen E.
  • bioRxiv
  • DOI: 10.1101/380931

Universal cancer tasks, evolutionary tradeoffs, and the functions of driver mutations
posted_content, August 2018

  • Hausser, Jean; Szekely, Pablo; Bar, Noam
  • BioRxiv
  • DOI: 10.1101/382291

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
journal, November 2019

  • Diossy, Miklos; Sztupinszki, Zsofia; Borcsok, Judit
  • npj Precision Oncology
  • DOI: 10.1101/576223

An integrative ENCODE resource for cancer genomics
journal, July 2019

  • Zhang, Jing; Lee, Donghoon; Dhiman, Vineet
  • Nature Communications
  • DOI: 10.1101/706424

The circular RNome of primary breast cancer
journal, January 2019

  • Smid, Marcel; Wilting, Saskia M.; Uhr, Katharina
  • Genome Research, Vol. 29, Issue 3
  • DOI: 10.1101/gr.238121.118

Saving the spandrels? Adaptive genomic variation in conservation and fisheries management: saving the spandrels
journal, October 2016


Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
journal, September 2017


Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features
journal, June 2019


Embryonal precursors of Wilms tumor
journal, December 2019


Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention
journal, March 2018


Interchromosomal Translocations as a Means to Map Chromosome Territories in Breast Cancer
journal, January 2019


Identification of coding and non-coding mutational hotspots in cancer genomes
journal, January 2017


CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
journal, July 2017

  • Stefansson, Olafur Andri; Hermanowicz, Stefan; van der Horst, Jasper
  • BMC Cancer, Vol. 17, Issue 1
  • DOI: 10.1186/s12885-017-3453-8

Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis
journal, November 2018


Therapeutic landscape in mutational triple negative breast cancer
journal, July 2018


Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
journal, June 2020


Depletion of somatic mutations in splicing-associated sequences in cancer genomes
journal, November 2017


Recurrent mutations at estrogen receptor binding sites alter chromatin topology and distal gene expression in breast cancer
journal, November 2018


Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents
journal, November 2019


Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas
journal, September 2018


Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer
journal, July 2019


Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models
journal, February 2019


APOBEC3A is a prominent cytidine deaminase in breast cancer
journal, December 2019


Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
journal, September 2018


Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia
journal, November 2019


High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
journal, August 2019


The challenges of modeling hormone receptor-positive breast cancer in mice
journal, May 2018

  • Özdemir, Berna C.; Sflomos, George; Brisken, Cathrin
  • Endocrine-Related Cancer, Vol. 25, Issue 5
  • DOI: 10.1530/erc-18-0063

The Unfolded Protein Response in Breast Cancer
journal, September 2018


Targeting DNA Replication Stress for Cancer Therapy
journal, August 2016


The cJUN NH2-terminal kinase (JNK) signaling pathway promotes genome stability and prevents tumor initiation
journal, June 2018

  • Girnius, Nomeda; Edwards, Yvonne JK; Garlick, David S.
  • eLife, Vol. 7
  • DOI: 10.7554/elife.36389

Somatic mutations in early metazoan genes disrupt regulatory links between unicellular and multicellular genes in cancer
journal, February 2019

  • Trigos, Anna S.; Pearson, Richard B.; Papenfuss, Anthony T.
  • eLife, Vol. 8
  • DOI: 10.7554/elife.40947

Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
journal, April 2020

  • Van Bockstal, Mieke R.; Agahozo, Marie Colombe; van Marion, Ronald
  • Molecular Oncology, Vol. 14, Issue 4
  • DOI: 10.1002/1878-0261.12650

Using gene expression data to direct breast cancer therapy: evidence from a preclinical trial
journal, January 2018

  • Reaz, Shams; Tamkus, Deimante; Andrechek, Eran R.
  • Journal of Molecular Medicine, Vol. 96, Issue 2
  • DOI: 10.1007/s00109-017-1620-7

CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
journal, July 2018

  • Aftab, Ayesha; Shahzad, Shaheen; Hussain, Hafiz Muhammad Jafar
  • Breast Cancer, Vol. 26, Issue 1
  • DOI: 10.1007/s12282-018-0894-0

Human genomics projects and precision medicine
journal, August 2017

  • Carrasco-Ramiro, F.; Peiró-Pastor, R.; Aguado, B.
  • Gene Therapy, Vol. 24, Issue 9
  • DOI: 10.1038/gt.2017.77

The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis
journal, September 2016

  • Starrett, Gabriel J.; Luengas, Elizabeth M.; McCann, Jennifer L.
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12918

Hereditary breast and ovarian cancer: new genes in confined pathways
journal, August 2016

  • Nielsen, Finn Cilius; van Overeem Hansen, Thomas; Sørensen, Claus Storgaard
  • Nature Reviews Cancer, Vol. 16, Issue 9
  • DOI: 10.1038/nrc.2016.72

Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition
journal, April 2018


BRCA1/2 testing: therapeutic implications for breast cancer management
journal, June 2018


Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes
journal, October 2017


Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
journal, April 2018


Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidates
journal, July 2018


Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
journal, December 2018


Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
journal, January 2019

  • Annunziato, Stefano; de Ruiter, Julian R.; Henneman, Linda
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-08301-2

Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability
journal, October 2018

  • Jing, Anqi; Vizeacoumar, Frederick S.; Parameswaran, Sreejit
  • npj Systems Biology and Applications, Vol. 4, Issue 1
  • DOI: 10.1038/s41540-018-0074-z

Breast cancer
journal, September 2019

  • Harbeck, Nadia; Penault-Llorca, Frédérique; Cortes, Javier
  • Nature Reviews Disease Primers, Vol. 5, Issue 1
  • DOI: 10.1038/s41572-019-0111-2

Patterns of somatic structural variation in human cancer genomes
journal, February 2020


Integrative detection and analysis of structural variation in cancer genomes
journal, September 2018


Chromosome segregation errors generate a diverse spectrum of simple and complex genomic rearrangements
journal, March 2019


ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
journal, January 2020


Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
journal, July 2017


The germline mutational landscape of BRCA1 and BRCA2 in Brazil
journal, June 2018

  • Palmero, Edenir Inêz; Carraro, Dirce Maria; Alemar, Barbara
  • Scientific Reports, Vol. 8, Issue 1
  • DOI: 10.1038/s41598-018-27315-2

Co-regulated gene expression of splicing factors as drivers of cancer progression
journal, April 2019


Frequent mutation of the FOXA1 untranslated region in prostate cancer
journal, August 2018

  • Annala, Matti; Taavitsainen, Sinja; Vandekerkhove, Gillian
  • Communications Biology, Vol. 1, Issue 1
  • DOI: 10.1038/s42003-018-0128-1

Genome-wide mapping of regions preferentially targeted by the human DNA-cytosine deaminase APOBEC3A using uracil-DNA pulldown and sequencing
journal, October 2019

  • Sakhtemani, Ramin; Senevirathne, Vimukthi; Stewart, Jessica
  • Journal of Biological Chemistry, Vol. 294, Issue 41
  • DOI: 10.1074/jbc.RA119.008053

Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy
journal, June 2019


MALAT1 long non-coding RNA and breast cancer
journal, March 2019


The Sequence Alignment/Map format and SAMtools
journal, June 2009


WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts
journal, July 2019

  • Jiang, Lin; Zheng, Jingjing; Kwan, Johnny S. H.
  • Nucleic Acids Research, Vol. 47, Issue 16
  • DOI: 10.1093/nar/gkz566

Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
posted_content, April 2017

  • Atak, Zeynep Kalender; Imrichova, Hana; Svetlichnyy, Dmitry
  • bioRxiv
  • DOI: 10.1101/130641

Comprehensive Analysis of Indels in Whole-genome Microsatellite Regions and Microsatellite Instability across 21 Cancer Types
posted_content, February 2019

  • Fujimoto, Akihiro; Fujita, Masashi; Hasegawa, Takanori
  • DOI: 10.1101/406975

Signatures of replication timing, recombination and sex in the spectrum of rare variants on the human X chromosome and autosomes
posted_content, May 2019

  • Agarwal, Ipsita; Przeworski, Molly
  • Proceedings of the National Academy of Sciences
  • DOI: 10.1101/519421

Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
journal, February 2017

  • Brammeld, Jonathan S.; Petljak, Mia; Martincorena, Inigo
  • Genome Research, Vol. 27, Issue 4
  • DOI: 10.1101/gr.213546.116

Homologous Recombination and Replication Fork Protection: BRCA2 and More!
journal, January 2017


Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers
journal, January 2020

  • Karaayvaz-Yildirim, Mihriban; Silberman, Rebecca E.; Langenbucher, Adam
  • Science Advances, Vol. 6, Issue 5
  • DOI: 10.1126/sciadv.aay2611

RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation
journal, August 2016

  • Jones, Robert A.; Robinson, Tyler J.; Liu, Jeff C.
  • Journal of Clinical Investigation, Vol. 126, Issue 10
  • DOI: 10.1172/jci81568

Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
journal, February 2018

  • Ullah, Ikram; Karthik, Govindasamy-Muralidharan; Alkodsi, Amjad
  • Journal of Clinical Investigation, Vol. 128, Issue 4
  • DOI: 10.1172/jci96149

Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer
journal, April 2018


Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
journal, February 2017


Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer
journal, December 2019

  • Nederlof, Iris; De Bortoli, Davide; Bareche, Yacine
  • Breast Cancer Research, Vol. 21, Issue 1
  • DOI: 10.1186/s13058-019-1239-4

Prioritization and functional assessment of noncoding variants associated with complex diseases
journal, July 2018


In vivo models in breast cancer research: progress, challenges and future directions
journal, April 2017

  • Holen, Ingunn; Speirs, Valerie; Morrissey, Bethny
  • Disease Models & Mechanisms, Vol. 10, Issue 4
  • DOI: 10.1242/dmm.028274

Software for Computing and Annotating Genomic Ranges
journal, August 2013


The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer
journal, August 2016


Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer
journal, January 2019


In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer
journal, January 2020


Defects in homologous recombination repair behind the human diseases: FA and HBOC
journal, October 2016

  • Katsuki, Yoko; Takata, Minoru
  • Endocrine-Related Cancer, Vol. 23, Issue 10
  • DOI: 10.1530/erc-16-0221

The circular RNome of primary breast cancer.
text, January 2019

  • Smid, Marcel; Wilting, Saskia M.; Uhr, Katharina
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.37373

Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.
text, January 2019

  • Caswell-Jin, Jennifer L.; McNamara, Katherine; Reiter, Johannes G.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.39254

Non-coding RNAs underlie genetic predisposition to breast cancer
text, January 2020

  • Moradi Marjaneh, Mahdi; Beesley, Jonathan; O’Mara, Tracy A.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.53441

Mutational signatures of ionizing radiation in second malignancies
text, January 2016

  • Behjati, Sam; Gundem, G.; Wedge, Dc
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.8737

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
posted_content, June 2020


Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
journal, December 2018


A sequential Monte Carlo algorithm for inference of subclonal structure in cancer
text, January 2019

  • Ogundijo, Oyetunji Enoch; Zhu, Kaiyi; Wang, Xiaodong
  • Columbia University
  • DOI: 10.7916/d8-cj4c-q275

Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly
journal, March 2019

  • Tervasmäki, Anna; Mantere, Tuomo; Eshraghi, Leila
  • International Journal of Cancer, Vol. 145, Issue 8
  • DOI: 10.1002/ijc.32234

MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB - NFIB fusion gene: MYB-NFIB -negative breast adenoid cystic carcinomas
journal, December 2017

  • Kim, Jisun; Geyer, Felipe C.; Martelotto, Luciano G.
  • The Journal of Pathology, Vol. 244, Issue 2
  • DOI: 10.1002/path.5006

Mechanisms of resistance to estrogen receptor modulators in ER+/HER2− advanced breast cancer
journal, August 2019


Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
journal, January 2020


Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?
journal, September 2016


Mechanism of tandem duplication formation in BRCA1-mutant cells
journal, November 2017

  • Willis, Nicholas A.; Frock, Richard L.; Menghi, Francesca
  • Nature, Vol. 551, Issue 7682
  • DOI: 10.1038/nature24477

BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance
journal, December 2017

  • Duarte, Alexandra A.; Gogola, Ewa; Sachs, Norman
  • Nature Methods, Vol. 15, Issue 2
  • DOI: 10.1038/nmeth.4535

Defining driver mutations in the genomic landscape of breast cancer
journal, May 2016


Capicua restricts cancer stem cell-like properties in breast cancer cells
journal, February 2020


Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
journal, December 2019

  • Yellapantula, Venkata; Hultcrantz, Malin; Rustad, Even H.
  • Blood Cancer Journal, Vol. 9, Issue 12
  • DOI: 10.1038/s41408-019-0264-y

The driver landscape of sporadic chordoma
journal, October 2017


Mutational signatures reveal the dynamic interplay of risk factors and cellular processes during liver tumorigenesis
journal, November 2017


Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
journal, April 2019


The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
journal, November 2019


Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
journal, February 2020


Transcriptomic response of breast cancer cells to anacardic acid
journal, May 2018


Challenges and future of precision medicine strategies for breast cancer based on a database on drug reactions
journal, September 2019

  • Zhang, Xiping; Yang, Hongjian; Zhang, Ruiping
  • Bioscience Reports, Vol. 39, Issue 9
  • DOI: 10.1042/bsr20190230

Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer
journal, January 2019

  • Roelofs, Charlotte; Hollande, Frédéric; Redvers, Richard
  • Biochemical Society Transactions, Vol. 47, Issue 1
  • DOI: 10.1042/bst20180375

FusionPro, a Versatile Proteogenomic Tool for Identification of Novel Fusion Transcripts and Their Potential Translation Products in Cancer Cells
journal, June 2019

  • Kim, Chae-Yeon; Na, Keun; Park, Saeram
  • Molecular & Cellular Proteomics, Vol. 18, Issue 8
  • DOI: 10.1074/mcp.ra119.001456

Olaparib for the treatment of breast cancer
journal, March 2018

  • Griguolo, Gaia; Dieci, Maria Vittoria; Guarneri, Valentina
  • Expert Review of Anticancer Therapy, Vol. 18, Issue 6
  • DOI: 10.1080/14737140.2018.1458613

The long noncoding RNA Malat1: Its physiological and pathophysiological functions
journal, October 2017


The whole-genome panorama of cancer drivers
posted_content, December 2017

  • Sabarinathan, Radhakrishnan; Pich, Oriol; Martincorena, Iñigo
  • bioRxiv
  • DOI: 10.1101/190330

Targeted mutation detection in breast cancer using MammaSeq™
journal, February 2018

  • Smith, Nicholas G.; Gyanchandani, Rekha; Gurda, Grzegorz
  • Breast Cancer Research
  • DOI: 10.1101/264267

Molecular features of premenopausal breast cancers in Latin American women: pilot results from the PRECAMA study
posted_content, August 2018

  • Olivier, Magali; Bouaoun, Liacine; Villar, Stephanie
  • PLOS ONE
  • DOI: 10.1101/396218

Comprehensive Genomic Characterization of Breast Tumors with BRCA1 and BRCA2 Mutations
journal, May 2019

  • Lal, Avantika; Ramazzotti, Daniele; Weng, Ziming
  • BMC Medical Genomics
  • DOI: 10.1101/409813

Genomic aberration based molecular signatures efficiently characterize homologous recombination deficiency in prostate cancer
posted_content, June 2019

  • Sztupinszki, Zsofia; Diossy, Miklos; Krzystanek, Marcin
  • BioRxiv
  • DOI: 10.1101/681114

Novel patterns of complex structural variation revealed across thousands of cancer genome graphs
posted_content, November 2019


Whole‐exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast
journal, October 2019

  • Beca, Francisco; Lee, Simon S. K.; Pareja, Fresia
  • Histopathology, Vol. 75, Issue 6
  • DOI: 10.1111/his.13962

Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine
journal, January 2017

  • Coyle, Krysta Mila; Boudreau, Jeanette E.; Marcato, Paola
  • BioMed Research International, Vol. 2017
  • DOI: 10.1155/2017/9620870

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer
journal, December 2018

  • Humphries, Matthew P.; Hynes, Sean; Bingham, Victoria
  • Journal of Oncology, Vol. 2018
  • DOI: 10.1155/2018/2937012

Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls
journal, June 2017

  • Buckley, Alexandra R.; Standish, Kristopher A.; Bhutani, Kunal
  • BMC Genomics, Vol. 18, Issue 1
  • DOI: 10.1186/s12864-017-3770-y

Portrait of a cancer: mutational signature analyses for cancer diagnostics
journal, May 2019


New generation breast cancer cell lines developed from patient-derived xenografts
journal, June 2020

  • Finlay-Schultz, Jessica; Jacobsen, Britta M.; Riley, Duncan
  • Breast Cancer Research, Vol. 22, Issue 1
  • DOI: 10.1186/s13058-020-01300-y

Structural rearrangements generate cell-specific, gene-independent CRISPR-Cas9 loss of fitness effects
journal, February 2019


Comprehensive pharmacogenomic characterization of gastric cancer
journal, February 2020


Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer
journal, June 2018

  • Rodríguez Bautista, Rubén; Ortega Gómez, Alette; Hidalgo Miranda, Alfredo
  • Clinical Epigenetics, Vol. 10, Issue 1
  • DOI: 10.1186/s13148-018-0514-z

Association analysis identifies 65 new breast cancer risk loci
text, January 2017

  • Michailidou, K.; Lindström, S.; Dennis, Joe
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.14358

Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants.
text, January 2018

  • Wegert, Jenny; Vokuhl, Christian; Collord, Grace
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.30395

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
text, January 2017

  • Ju, Young Seok; Martincorena, Inigo; Gerstung, Moritz
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.39621

Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.
text, January 2019

  • Davies, Helen; Hodgson, Kirsty; Schwalbe, Edward
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.45836

The repertoire of mutational signatures in human cancer
text, January 2020

  • Alexandrov, Ludmil B.; Kim, Jaegil; Haradhvala, Nicholas J.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.64271

Pan-cancer analysis of whole genomes.
text, January 2020

  • Consortium, ICGC/TCGA Pan-Cancer Analysis Of Whole Genomes
  • The Francis Crick Institute
  • DOI: 10.25418/crick.11876919

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
text, January 2021


Therapeutic Targeting of the IGF Axis
journal, August 2019


PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
journal, March 2019

  • Keung, Man; Wu, Yanyuan; Vadgama, Jaydutt
  • Journal of Clinical Medicine, Vol. 8, Issue 4
  • DOI: 10.3390/jcm8040435

Perturbation of base excision repair sensitizes breast cancer cells to APOBEC3 deaminase-mediated mutations
journal, January 2020

  • Shen, Birong; Chapman, Joseph H.; Custance, Michael F.
  • eLife, Vol. 9
  • DOI: 10.7554/elife.51605

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
journal, August 2019

  • Lindholm, Evita Maria; Ragle Aure, Miriam; Haugen, Mads Haugland
  • Molecular Oncology, Vol. 13, Issue 10
  • DOI: 10.1002/1878-0261.12561

The anaphase‐promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer
journal, October 2019

  • Melloy, Patricia G.
  • Genes, Chromosomes and Cancer, Vol. 59, Issue 3
  • DOI: 10.1002/gcc.22820

Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
journal, April 2019

  • Wang, Xiaozhen; Liu, Haimeng; Maimaitiaili, Amina
  • Molecular Genetics & Genomic Medicine, Vol. 7, Issue 6
  • DOI: 10.1002/mgg3.677

Targeting DNA repair: the genome as a potential biomarker: Predictive genomic biomarkers in cancer
journal, February 2018

  • Nesic, Ksenija; Wakefield, Matthew; Kondrashova, Olga
  • The Journal of Pathology, Vol. 244, Issue 5
  • DOI: 10.1002/path.5025

Recent advances in breast cancer research impacting clinical diagnostic practice
journal, January 2019

  • McCart Reed, Amy E.; Kalita‐De Croft, Priyakshi; Kutasovic, Jamie R.
  • The Journal of Pathology, Vol. 247, Issue 5
  • DOI: 10.1002/path.5199

Constrained De Novo Sequencing of neo-Epitope Peptides Using Tandem Mass Spectrometry
book, January 2018


Mutant p53 in breast cancer: potential as a therapeutic target and biomarker
journal, March 2018

  • Duffy, Michael J.; Synnott, Naoise C.; Crown, John
  • Breast Cancer Research and Treatment, Vol. 170, Issue 2
  • DOI: 10.1007/s10549-018-4753-7

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment
journal, April 2018

  • Wilkins, Anna; Chauhan, Ritika; Rust, Alistair
  • Breast Cancer Research and Treatment, Vol. 170, Issue 3
  • DOI: 10.1007/s10549-018-4798-7

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
journal, August 2017


Whole-genome sequencing reveals genomic signatures associated with the inflammatory microenvironments in Chinese NSCLC patients
journal, May 2018


Genomic patterns of progression in smoldering multiple myeloma
journal, August 2018


The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
journal, August 2018


A unified haplotype-based method for accurate and comprehensive variant calling
journal, March 2021


High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
journal, November 2019


Signatures of positive selection reveal a universal role of chromatin modifiers as cancer driver genes
journal, October 2017


The Ras-related gene ERAS is involved in human and murine breast cancer
journal, August 2018

  • Suárez-Cabrera, Cristian; de la Peña, Bárbara; González, Laura L.
  • Scientific Reports, Vol. 8, Issue 1
  • DOI: 10.1038/s41598-018-31326-4

The canonical non-homologous end joining factor XLF promotes chromosomal deletion rearrangements in human cells
journal, January 2020

  • Bhargava, Ragini; Lopezcolorado, Felicia Wednesday; Tsai, L. Jillianne
  • Journal of Biological Chemistry, Vol. 295, Issue 1
  • DOI: 10.1074/jbc.ra119.010421

The evolving role of receptors as predictive biomarkers for metastatic breast cancer
journal, December 2018

  • Martínez-Pérez, Carlos; Turnbull, Arran K.; Dixon, J. Michael
  • Expert Review of Anticancer Therapy, Vol. 19, Issue 2
  • DOI: 10.1080/14737140.2019.1552138

Journey’s end: the quest for BRCA-like hereditary breast cancer genes is nearly over
journal, May 2019


Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
journal, April 2019


Germline microsatellite genotypes differentiate children with medulloblastoma
journal, September 2019

  • Rivero-Hinojosa, Samuel; Kinney, Nicholas; Garner, Harold R.
  • Neuro-Oncology, Vol. 22, Issue 1
  • DOI: 10.1093/neuonc/noz179

APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context
posted_content, May 2016

  • Seplyarskiy, Vladimir B.; Andrianova, Maria A.; Bazykin, Georgii A.
  • bioRxiv
  • DOI: 10.1101/054197

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
journal, October 2019

  • Zhang, Haoyu; Ahearn, Thomas U.; Lecarpentier, Julie
  • Nature Genetics
  • DOI: 10.1101/778605

Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
journal, April 2018

  • Schuh, Anna; Dreau, Helene; Knight, Samantha J. L.
  • Molecular Case Studies, Vol. 4, Issue 2
  • DOI: 10.1101/mcs.a002279

A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling
journal, January 2019

  • Wang, Dong-Yu; Gendoo, Deena M. A.; Ben-David, Yaacov
  • Breast Cancer Research, Vol. 21, Issue 1
  • DOI: 10.1186/s13058-019-1098-z

Comprehensive evaluation of structural variation detection algorithms for whole genome sequencing
journal, June 2019


Modelling the MYC-driven normal-to-tumour switch in breast cancer
journal, July 2019

  • Lourenco, Corey; Kalkat, Manpreet; Houlahan, Kathleen E.
  • Disease Models & Mechanisms, Vol. 12, Issue 7
  • DOI: 10.1242/dmm.038083

Breaking point: the genesis and impact of structural variation in tumours
journal, January 2018


De novo mutational signature discovery in tumor genomes using SparseSignatures
journal, June 2021


Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers
journal, April 2018


Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
journal, January 2019

  • Macedo, Gabriel S.; Alemar, Barbara; Ashton-Prolla, Patricia
  • Genetics and Molecular Biology, Vol. 42, Issue 1 suppl 1
  • DOI: 10.1590/1678-4685-gmb-2018-0104

Computational approaches for discovery of mutational signatures in cancer.
text, January 2019

  • Baez-Ortega, Adrian; Gori, Kevin
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.11113

Validating the concept of mutational signatures with isogenic cell models.
text, January 2018

  • Zou, Xueqing; Owusu, Michel; Harris, Rebecca
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.24971

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.
text, January 2016

  • Smid, Marcel; Rodríguez-González, F. Germán; Sieuwerts, Anieta M.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.30321

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
text, January 2021


GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
journal, January 2019


Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
journal, October 2019


Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage
journal, August 2016

  • Stork, Caroline Townsend; Bocek, Michael; Crossley, Madzia P.
  • eLife, Vol. 5
  • DOI: 10.7554/elife.17548

ascatNgs: Identifying Somatically Acquired Copy-Number Alterations from Whole-Genome Sequencing Data: ascatNgs: Identifying Copy-number Alterations from Sequencing Data
journal, December 2016

  • Raine, Keiran M.; Van Loo, Peter; Wedge, David C.
  • Current Protocols in Bioinformatics, Vol. 56, Issue 1
  • DOI: 10.1002/cpbi.17

Emerging Role of Genomics and Cell-Free DNA in Breast Cancer
journal, June 2019

  • Gerratana, Lorenzo; Davis, Andrew A.; Shah, Ami N.
  • Current Treatment Options in Oncology, Vol. 20, Issue 8
  • DOI: 10.1007/s11864-019-0667-9

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
journal, September 2016

  • Smid, Marcel; Rodríguez-González, F. Germán; Sieuwerts, Anieta M.
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12910

Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
journal, March 2018

  • Salk, Jesse J.; Schmitt, Michael W.; Loeb, Lawrence A.
  • Nature Reviews Genetics, Vol. 19, Issue 5
  • DOI: 10.1038/nrg.2017.117

Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
journal, July 2020


Fibroblast growth factor receptors as treatment targets in clinical oncology
journal, October 2018


The repertoire of mutational signatures in human cancer
journal, February 2020


Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
journal, January 2020


In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
journal, June 2019


Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
journal, August 2019

  • Vallon-Christersson, Johan; Häkkinen, Jari; Hegardt, Cecilia
  • Scientific Reports, Vol. 9, Issue 1
  • DOI: 10.1038/s41598-019-48570-x

Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction
journal, August 2017

  • Dimitrakopoulos, Lampros; Prassas, Ioannis; Diamandis, Eleftherios P.
  • Critical Reviews in Clinical Laboratory Sciences, Vol. 54, Issue 6
  • DOI: 10.1080/10408363.2017.1384446

NEAT1-containing paraspeckles: Central hubs in stress response and tumor formation
journal, October 2016


Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology
journal, December 2017

  • Ziogas, Demosthenes E.; Kyrochristos, Ioannis D.; Roukos, Dimitrios H.
  • Expert Review of Medical Devices, Vol. 15, Issue 1
  • DOI: 10.1080/17434440.2017.1419059

Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
journal, April 2019

  • Yost, Shawn; Ruark, Elise; Alexandrov, Ludmil B.
  • JNCI Cancer Spectrum, Vol. 3, Issue 2
  • DOI: 10.1093/jncics/pkz028

An Integrative Framework for Detecting Structural Variations in Cancer Genomes
posted_content, March 2017

  • Dixon, Jesse R.; Xu, Jie; Dileep, Vishnu
  • bioRxiv
  • DOI: 10.1101/119651

Candidate cancer driver mutations in superenhancers and long-range chromatin interaction networks
journal, December 2017

  • Wadi, Lina; Uusküla-Reimand, Liis; Isaev, Keren
  • Molecular Cell
  • DOI: 10.1101/236802

Integrated single-nucleotide and structural variation signatures of DNA-repair deficient human cancers
posted_content, February 2018


Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
posted_content, June 2020

  • Vöhringer, Harald; Hoeck, Arne van; Cuppen, Edwin
  • DOI: 10.1101/850453

Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study
journal, April 2019

  • Sunami, Kuniko; Ichikawa, Hitoshi; Kubo, Takashi
  • Cancer Science, Vol. 110, Issue 4
  • DOI: 10.1111/cas.13969

Relation between DNA ionization potentials, single base substitutions and pathogenic variants
journal, July 2019


Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
journal, June 2019


Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families
journal, April 2020

  • Van Marcke, Cédric; Helaers, Raphaël; De Leener, Anne
  • Breast Cancer Research, Vol. 22, Issue 1
  • DOI: 10.1186/s13058-020-01273-y

Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency
journal, June 2017


The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers.
text, January 2018

  • Weigelt, Britta; Bi, Rui; Kumar, Rahul
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.25796

Homologous recombination DNA repair defects in PALB2-associated breast cancers.
text, January 2019

  • Li, Anqi; Geyer, Felipe C.; Blecua, Pedro
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.40684

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
text, January 2017

  • Davies, Helen; Glodzik, Dominik; Morganella, Sandro
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.61944

Butler enables rapid cloud-based analysis of thousands of human genomes.
text, January 2020

  • Yakneen, Sergei; Waszak, Sebastian M.; Group, PCAWG Technical Working
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.64279

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
journalarticle, January 2020

  • Cortés-Ciriano, Isidro; Lee, Jake June-Koo; Xi, Ruibin
  • Springer Science and Business Media LLC
  • DOI: 10.17863/cam.73656

Single peptides and combination modalities for triple negative breast cancer
journal, October 2019

  • Razazan, Atefeh; Behravan, Javad
  • Journal of Cellular Physiology
  • DOI: 10.1002/jcp.29300

Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications
journal, February 2017

  • Pareja, Fresia; Marchiò, Caterina; Geyer, Felipe C.
  • Current Breast Cancer Reports, Vol. 9, Issue 1
  • DOI: 10.1007/s12609-017-0233-z

A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
journal, January 2017

  • Glodzik, Dominik; Morganella, Sandro; Davies, Helen
  • Nature Genetics, Vol. 49, Issue 3
  • DOI: 10.1038/ng.3771

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance
journal, November 2017


Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors
journal, November 2018


Piercing the dark matter: bioinformatics of long-range sequencing and mapping
journal, March 2018

  • Sedlazeck, Fritz J.; Lee, Hayan; Darby, Charlotte A.
  • Nature Reviews Genetics, Vol. 19, Issue 6
  • DOI: 10.1038/s41576-018-0003-4

Detecting the mutational signature of homologous recombination deficiency in clinical samples
journal, April 2019

  • Gulhan, Doga C.; Lee, Jake June-Koo; Melloni, Giorgio E. M.
  • Nature Genetics, Vol. 51, Issue 5
  • DOI: 10.1038/s41588-019-0390-2

Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
journal, September 2019


Effects of short indels on protein structure and function in human genomes
journal, August 2017


Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer
journal, February 2020


Cancer Target Gene Screening: a web application for breast cancer target gene screening using multi-omics data analysis
journal, January 2019

  • Kim, Hyung-Yong; Choi, Hee-Joo; Lee, Jeong-Yeon
  • Briefings in Bioinformatics, Vol. 21, Issue 2
  • DOI: 10.1093/bib/bbz003

Detecting presence of mutational signatures in cancer with confidence
journal, September 2017


Hidden Markov Models Lead to Higher Resolution Maps of Mutation Signature Activity in Cancer
posted_content, August 2018

  • Huang, Xiaoqing; Sason, Itay; Wojtowicz, Damian
  • Genome Medicine
  • DOI: 10.1101/392639

Epigenetic dysregulation underpins tumorigenesis in a cutaneous tumor syndrome
posted_content, July 2019

  • Davies, Helen R.; Hodgson, Kirsty; Schwalbe, Edward
  • bioRxiv
  • DOI: 10.1101/687459

Aneuploidy and deregulated DNA damage response define haploinsufficiency in breast tissues of BRCA2 mutation carriers
posted_content, August 2019

  • Karaayvaz, Mihriban; Silberman, Rebecca E.; Langenbucher, Adam
  • bioRxiv
  • DOI: 10.1101/729301

Optical mapping reveals a higher level of genomic architecture of chained fusions in cancer
journal, April 2018

  • Chan, Eva K. F.; Cameron, Daniel L.; Petersen, Desiree C.
  • Genome Research, Vol. 28, Issue 5
  • DOI: 10.1101/gr.227975.117

Coexisting genomic aberrations associated with lymph node metastasis in breast cancer
journal, April 2018

  • Bao, Li; Qian, Zhaoyang; Lyng, Maria B.
  • Journal of Clinical Investigation, Vol. 128, Issue 6
  • DOI: 10.1172/jci97449

Novel mutations in actionable breast cancer genes by targeted sequencing in an ethnically homogenous cohort
journal, September 2019


Chromatin interactome mapping at 139 independent breast cancer risk signals
journal, January 2020

  • Beesley, Jonathan; Sivakumaran, Haran; Moradi Marjaneh, Mahdi
  • Genome Biology, Vol. 21, Issue 1
  • DOI: 10.1186/s13059-019-1877-y

The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues
journal, May 2020


Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer
journal, February 2017


A practical guide for mutational signature analysis in hematological malignancies
text, January 2019

  • Maura, Francesco; Degasperi, Andrea; Nadeu, Ferran
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.54705

Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome
text, January 2019

  • Davies, Helen R.; Hodgson, Kirsty; Schwalbe, Edward
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.58697

Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
text, January 2017

  • Foo, Tk; Tischkowitz, Marc; Simhadri, S.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.61942

Pan-cancer analysis of whole genomes
text, January 2020

  • Consortium, The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes; J., Campbell, Peter; Gunnar, Rätsch,
  • ETH Zurich
  • DOI: 10.3929/ethz-b-000399331

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas
text, January 2018

  • Geyer, Felipe C.; Li, Anqi; Papanastasiou, Anastasios D.
  • Nature Publishing Group
  • DOI: 10.5167/uzh-151485

miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
journal, August 2019

  • Lindholm, Evita Maria; Ragle Aure, Miriam; Haugen, Mads Haugland
  • Molecular Oncology, Vol. 13, Issue 10
  • DOI: 10.1002/1878-0261.12561

Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly
journal, March 2019

  • Tervasmäki, Anna; Mantere, Tuomo; Eshraghi, Leila
  • International Journal of Cancer, Vol. 145, Issue 8
  • DOI: 10.1002/ijc.32234

Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria
journal, June 2019

  • Wang, Shengfeng; Pitt, Jason J.; Zheng, Yonglan
  • International Journal of Cancer, Vol. 145, Issue 12
  • DOI: 10.1002/ijc.32498

Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high‐risk breast cancer
journal, April 2019

  • Wang, Xiaozhen; Liu, Haimeng; Maimaitiaili, Amina
  • Molecular Genetics & Genomic Medicine, Vol. 7, Issue 6
  • DOI: 10.1002/mgg3.677

Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
journal, February 2017

  • de Oliveira Taveira, Mateus; Nabavi, Sheida; Wang, Yuker
  • Journal of Cancer Research and Clinical Oncology, Vol. 143, Issue 7
  • DOI: 10.1007/s00432-017-2358-x

Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells
journal, January 2020


Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy
journal, August 2016

  • Zhang, Weiguo; Mao, Jian-Hua; Zhu, Wei
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12619

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
journal, September 2016

  • Smid, Marcel; Rodríguez-González, F. Germán; Sieuwerts, Anieta M.
  • Nature Communications, Vol. 7, Issue 1
  • DOI: 10.1038/ncomms12910

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
journal, December 2016

  • Shi, Ke; Carpenter, Michael A.; Banerjee, Surajit
  • Nature Structural & Molecular Biology, Vol. 24, Issue 2
  • DOI: 10.1038/nsmb.3344

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
journal, December 2019

  • Yellapantula, Venkata; Hultcrantz, Malin; Rustad, Even H.
  • Blood Cancer Journal, Vol. 9, Issue 12
  • DOI: 10.1038/s41408-019-0264-y

BRCA1/2 testing: therapeutic implications for breast cancer management
journal, June 2018


Molecular heterogeneity and early metastatic clone selection in testicular germ cell cancer development
journal, February 2019

  • Dorssers, Lambert C. J.; Gillis, Ad J. M.; Stoop, Hans
  • British Journal of Cancer, Vol. 120, Issue 4
  • DOI: 10.1038/s41416-019-0381-1

Genomic patterns of progression in smoldering multiple myeloma
journal, August 2018


The therapeutic significance of mutational signatures from DNA repair deficiency in cancer
journal, August 2018


Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
journal, February 2019

  • Caswell-Jin, Jennifer L.; McNamara, Katherine; Reiter, Johannes G.
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-08593-4

Breast cancer quantitative proteome and proteogenomic landscape
journal, April 2019

  • Johansson, Henrik J.; Socciarelli, Fabio; Vacanti, Nathaniel M.
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-019-09018-y

Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
journal, July 2019


Detailed modeling of positive selection improves detection of cancer driver genes
journal, July 2019


Tumor diversity and the trade-off between universal cancer tasks
journal, November 2019


Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort
journal, February 2017


Unique metabolic traits identify CCPAP
journal, April 2019


Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
journal, February 2020


Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
journal, September 2019


Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency
journal, February 2019


Co-regulated gene expression of splicing factors as drivers of cancer progression
journal, April 2019


In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
journal, June 2019


Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
journal, August 2019

  • Vallon-Christersson, Johan; Häkkinen, Jari; Hegardt, Cecilia
  • Scientific Reports, Vol. 9, Issue 1
  • DOI: 10.1038/s41598-019-48570-x

Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
journal, February 2017

  • Marotta, Michael; Onodera, Taku; Johnson, Jeffrey
  • Scientific Reports, Vol. 7, Issue 1
  • DOI: 10.1038/srep41921

Signatures of replication timing, recombination, and sex in the spectrum of rare variants on the human X chromosome and autosomes
journal, August 2019

  • Agarwal, Ipsita; Przeworski, Molly
  • Proceedings of the National Academy of Sciences, Vol. 116, Issue 36
  • DOI: 10.1073/pnas.1900714116

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
journal, April 2017


Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
journal, July 2019


The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
journal, April 2019

  • Mandelker, Diana; Kumar, Rahul; Pei, Xin
  • JNCI Cancer Spectrum, Vol. 3, Issue 2
  • DOI: 10.1093/jncics/pkz027

The BioGRID interaction database: 2017 update
journal, December 2016

  • Chatr-aryamontri, Andrew; Oughtred, Rose; Boucher, Lorrie
  • Nucleic Acids Research, Vol. 45, Issue D1
  • DOI: 10.1093/nar/gkw1102

Rev1 is a base excision repair enzyme with 5′-deoxyribose phosphate lyase activity
journal, September 2016

  • Prasad, Rajendra; Poltoratsky, Vladimir; Hou, Esther W.
  • Nucleic Acids Research, Vol. 44, Issue 22
  • DOI: 10.1093/nar/gkw869

Short inverted repeats contribute to localized mutability in human somatic cells
journal, August 2017

  • Zou, Xueqing; Morganella, Sandro; Glodzik, Dominik
  • Nucleic Acids Research, Vol. 45, Issue 19
  • DOI: 10.1093/nar/gkx731

Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures
journal, May 2018

  • Lee, Jongkeun; Lee, Andy Jinseok; Lee, June-Koo
  • Nucleic Acids Research, Vol. 46, Issue W1
  • DOI: 10.1093/nar/gky406

WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts
journal, July 2019

  • Jiang, Lin; Zheng, Jingjing; Kwan, Johnny S. H.
  • Nucleic Acids Research, Vol. 47, Issue 16
  • DOI: 10.1093/nar/gkz566

Identification of cis-regulatory mutations generating de novo edges in personalized cancer gene regulatory networks
posted_content, April 2017

  • Atak, Zeynep Kalender; Imrichova, Hana; Svetlichnyy, Dmitry
  • bioRxiv
  • DOI: 10.1101/130641

Expression-based analyses indicate a central role for hypoxia in driving tumor plasticity through microenvironment remodeling and chromosomal instability
journal, May 2018

  • Jing, Anqi; Vizeacoumar, Frederick S.; Parameswaran, Sreejit
  • npj Systems Biology and Applications
  • DOI: 10.1101/333633

BATCAVE: Calling somatic mutations with a tumor- and site-specific prior
posted_content, October 2019


The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer
journal, October 2016

  • Law, Emily K.; Sieuwerts, Anieta M.; LaPara, Kelly
  • Science Advances, Vol. 2, Issue 10
  • DOI: 10.1126/sciadv.1601737

Interchromosomal Translocations as a Means to Map Chromosome Territories in Breast Cancer
journal, January 2019


Identification of coding and non-coding mutational hotspots in cancer genomes
journal, January 2017


Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls
journal, June 2017

  • Buckley, Alexandra R.; Standish, Kristopher A.; Bhutani, Kunal
  • BMC Genomics, Vol. 18, Issue 1
  • DOI: 10.1186/s12864-017-3770-y

Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer
journal, April 2018


CoMutPlotter: a web tool for visual summary of mutations in cancer cohorts
journal, July 2019


Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer
journal, December 2019

  • Nederlof, Iris; De Bortoli, Davide; Bareche, Yacine
  • Breast Cancer Research, Vol. 21, Issue 1
  • DOI: 10.1186/s13058-019-1239-4

Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug Sensitivity
journal, September 2016


Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency
journal, June 2017


High expression of the vacuole membrane protein 1 (VMP1) is a potential marker of poor prognosis in HER2 positive breast cancer
journal, August 2019


Transcriptional regulation of normal human mammary cell heterogeneity and its perturbation in breast cancer
journal, January 2019


Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
journal, January 2019

  • Macedo, Gabriel S.; Alemar, Barbara; Ashton-Prolla, Patricia
  • Genetics and Molecular Biology, Vol. 42, Issue 1 suppl 1
  • DOI: 10.1590/1678-4685-gmb-2018-0104

Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers.
journalarticle, January 2018


Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study
journal, October 2016


The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
journal, November 2017


Somatic mutations in early onset luminal breast cancer
journal, April 2018

  • Encinas, Giselly; Sabelnykova, Veronica Y.; de Lyra, Eduardo Carneiro
  • Oncotarget, Vol. 9, Issue 32
  • DOI: 10.18632/oncotarget.25123

Prediction of circRNAs Based on the DNA Methylation-Mediated Feature Sponge Function in Breast Cancer
journal, June 2019


Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
journal, May 2017

  • McVeigh, Terri P.; Kerin, Michael J.
  • Breast Cancer: Targets and Therapy, Vol. Volume 9
  • DOI: 10.2147/bctt.s109847

‘Omics Approaches to Explore the Breast Cancer Landscape
journal, January 2020

  • Parsons, Joseph; Francavilla, Chiara
  • Frontiers in Cell and Developmental Biology, Vol. 7
  • DOI: 10.3389/fcell.2019.00395

Computational Methods for Characterizing Cancer Mutational Heterogeneity
journal, June 2017


Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial–Mesenchymal Spectrum in Cancer and Non-tumorigenic Cells
journal, January 2020

  • Panchy, Nicholas; Azeredo-Tseng, Cassandra; Luo, Michael
  • Frontiers in Oncology, Vol. 9
  • DOI: 10.3389/fonc.2019.01479

GDNF and the RET Receptor in Cancer: New Insights and Therapeutic Potential
journal, January 2019


CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
journal, November 2019


Targeting DNA Replication Stress for Cancer Therapy
journal, August 2016


Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
journal, January 2017

  • Saunus, Jodi; McCart Reed, Amy; Lim, Zhun
  • International Journal of Molecular Sciences, Vol. 18, Issue 1
  • DOI: 10.3390/ijms18010152

Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication
journal, December 2018


Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage
journal, August 2016

  • Stork, Caroline Townsend; Bocek, Michael; Crossley, Madzia P.
  • eLife, Vol. 5
  • DOI: 10.7554/elife.17548

A sequential Monte Carlo algorithm for inference of subclonal structure in cancer
text, January 2019

  • Ogundijo, Oyetunji Enoch; Zhu, Kaiyi; Wang, Xiaodong
  • Columbia University
  • DOI: 10.7916/d8-cj4c-q275